XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™
We received from XORTX Therapeutics Inc. and we are glad to publish the following press release: "Contract manufacturing of GMP drug substance and commercial-scale tablets to support the XRX-OXY-102 clinical study and future US FDA marketing approval ● CALGARY, Alberta, Sept. 10, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX"…